Steven Robins.

  
ROCHESTER, N.Y.—CooperVision announced it has appointed Steven Robins as president, Americas, effective immediately. Alex Wilkes was previously in the role, but left in August 2024 to accept a new role as president of National Vision. The position has been vacant since then, according to CooperVision. “Since my first foray into ocular health almost 20 years ago, I have known that there’s something special about this industry, shown by the way its professionals and products come together to make the world better for millions of people every day," said Robins. "There are big opportunities in vision care, and CooperVision is a clear leader in several."

Robins is a health care veteran, with three decades of experience in the industry. He was most recently managing partner and principal for New England Consulting Group, where he worked with a range of Fortune 500 organizations across the medical device, pharmaceutical and OTC/vitamin sector, according to the announcement. Among these were strategic engagements with CooperVision, including the U.S. introduction of its MiSight 1-day contact lens for myopia control.

He has also served as chief marketing officer and president of North American vision care for Bausch + Lomb, general manager of Johnson & Johnson’s consumer health care business in Canada and group marketing director for Pfizer Consumer Healthcare.

“Steven has been working with CooperVision for a number of years on strategic, priority projects including our MiSight 1-day contact lenses," said Debbie Olive, CooperVision's chief commercial officer. "I am impressed with his strategic thinking as well as his passion for the industry and our customers. He is a charismatic, engaging leader who undoubtedly will drive positive impacts throughout our Americas business."

Robins holds a BA from Bates College and has participated in the Pfizer Global Leadership Program with Harvard University. He plans to relocate to Rochester, a community that he has called home for several years.